In part one of our four-part series on the journey our academic customers go through while working with Cambridge Cognition – we focus on our sales team and the work they put in to ensure that we truly understand your research needs.
To understand the impact of COVID-19 on cognitive function, researchers must use sensitive and reliable cognitive assessments which target appropriate domains. In this article Operational Scientist, Iona Pickett, discusses the challenges of designing a cognitive testing battery for use in those recovering from COVID-19 and describes our recommended CANTAB battery for COVID-19 studies.
While several initiatives have begun investigating the neuropsychological effects of COVID-19, the nature and causes of cognitive impairment found in COVID-19 survivors are not yet fully understood. In this article Operational Scientist, Iona Pickett, discusses the challenges faced by researchers assessing cognition in those recovering from COVID-19.
We caught up with Julius Rave to talk about the impact that the primary 2021 CANTAB Research Grant prize will have on his research: Exploring structural and functional changes in memory-associated networks in patients expressing cognitive deficits after a COVID-19 infection.
Pim Heckman speaks to us about the impact that receiving one of the three 2021 CANTAB Research Grant prizes will have on his research into clearing COVID-19 cognitive brain fog
Jamileth More recently spoke to us about the impact that receiving one of the three 2021 CANTAB Research Grant prizes will have on her research into monitoring protocol of COVID-19 patients survivors of mechanical ventilation.
The results of the 2021 CANTAB Research Grant are in! This year's award was focussed on the connection between cognition and COVID-19.
Nearly a year on from the first outbreak of COVID-19, we still have a lot to learn about how the virus works and affects our health. In this article Operational Scientist, Iona Pickett, explores our current understanding of the neuropsychological consequences of COVID-19, in particular the impact on cognitive function.
Ciara Molloy recently spoke to us about the impact that receiving one of the three 2020 CANTAB Research Grant prizes will have on her research: ‘The impact of rare copy number variants on cognition: Defining cognitive phenotypes in individuals with CNVs associated with neurodevelopmental and neuropsychiatric disorders.’
2020 CANTAB Research Grant supports research into combined dexmedetomidine / ketamine nasal spray fo
The winner of one of the three 2020 CANTAB Research Grant prizes, Dr Amie Hayley, Swinburne University of Technology explains the impact CANTAB will have on her research: Combined dexmedetomidine/ketamine nasal spray for analgesia: a pilot feasibility and efficacy trial.
Dr Simone De Luca recently received the 2020 CANTAB Research Grant primary award for her project: “New ways to assess vascular cognitive impairment and dementia (VCID) in chronic lung disease”. We spoke to her about the impact winning would have on her research.
The results of the 2020 CANTAB Research Grant are in! Once again we were overwhelmed by the quality of applications we received – which made it a tough job for our judging panel to narrow the research proposals down.
The results of the 2019 CANTAB Research Grant are in! Once again we were overwhelmed by the quality of applications we received – which made it a tough job for our judging panel to narrow the research proposals down.
PhD Student Naoise Mac Giollabhui received a CANTAB Research Grant in 2018 for his project: ‘Chronic inflammation as a pathway to cognitive dysfunction in adolescents and young adults with a history of elevated depressive symptoms’. We caught up with Naoise to discuss how the grant will benefit his research.
The results of the 2018 CANTAB Research Grant are in! Once again we were overwhelmed by the quality of applications we received – which made it a tough job for our judging panel to narrow the research proposals down.
Winner of the 2016 Global Prize for the CANTAB Research Grant, Toni McCrossin, Clinical Officer for the New South Wales Brain Tissue Resource Centre (NSWBTRC) explains how access to CANTAB cognitive assessments are supporting their project.
The 2017 CANTAB Research Grant was once again overwhelmed with applications. All the research proposals received were such high quality it was another impossible task for our funding committee to review and narrow the proposals down. We received applications from across the globe from Hong Kong to Saint Lucia. But there could only be three awards.
PhD student Claire Burley was one of four winners of our CANTAB Research Grant for 2016. Claire was awarded our UK award for her study titled 'Multi-modal assessment of brain health across the lifespan and between fitness groups. Magnetic resonance imaging (MRI) meets Doppler ultrasound, cognitive function and measures of well-being'. Having now completed the majority of her research, Claire tells us more about her research project and how The CANTAB Research Grant has helped.
The early identification of individuals at risk of Alzheimer's Disease (AD) is of primary importance for the development of new effective interventions to stop the progression of the disease before the onset of severe neurodegeneration and clinical manifestations.